SHA:600062 Market Cap

SHA:600062 has a market cap or net worth of 19.17 billion as of April 8, 2026. Its market cap has decreased by -2.55% in one year.

Market Cap

19.17B

Enterprise Value

18.83B

Revenue

11.00B

Ranking

n/a

PE Ratio

11.65

Stock Price

18.56

Market Cap Chart

Since March 1, 2004, SHA:600062's market cap has increased from 9.40B to 19.17B, an increase of 103.84%. That is a compound annual growth rate of 3.27%.

Market Cap History

Date	Market Cap	% Change
Apr 8, 2026	19.17B	1.50%
Dec 31, 2025	18.89B	-7.08%
Dec 31, 2024	20.32B	5.43%
Dec 29, 2023	19.28B	5.47%
Dec 30, 2022	18.28B	31.03%
Dec 31, 2021	13.95B	11.51%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Tasly Pharmaceutical Group	21.02B
Jilin Aodong Pharmaceutical Group	20.55B
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd	20.32B
Walvax Biotechnology	20.23B
Joincare Pharmaceutical Group Industry	19.97B
Apeloa Pharmaceutical Co.,Ltd	19.93B
Tonghua Dongbao Pharmaceutical	19.42B
Fujian Cosunter Pharmaceutical	19.16B

Market Cap Rankings